Meeting
2016 Genitourinary Cancers Symposium
Prognostic factors of adjuvant chemotherapy with taxane, cisplatin, and 5FU combination (TPF) in patients (pts) with nodal metastases of penile squamous cell carcinoma (PSCC).
Authors
Andrea Necchi
Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Andrea Necchi , Salvatore Lo Vullo , Nicola Nicolai , Daniele Raggi , Patrizia Giannatempo , Maurizio Colecchia , Mario Catanzaro , Tullio Torelli , Luigi Piva , Davide Biasoni , Silvia Stagni , Luigi Mariani , Roberto Salvioni
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, and Testicular Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Penile, Urethral, and Testicular Cancers
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 479)
DOI
10.1200/jco.2016.34.2_suppl.479
Abstract #
479
Poster Bd #
L4
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
Pilot study of cisplatin, 5-fluorouracil, and a taxane (TPF) for advanced squamous cell carcinoma (SCC) of the penis.
First Author: R. Salvioni
Poster
2023 ASCO Annual Meeting
Atezolizumab plus tiragolumab in combination with chemoradiotherapy in localized squamous cell carcinoma of the anal canal: TIRANUS (GEMCAD-2103) trial.
First Author: Jaume Capdevila
Poster
2017 Gastrointestinal Cancers Symposium
Impact of cyclophilin A on survival in gastric cancer patients who received platinum-based chemotherapy.
First Author: Chi Hoon Maeng